BRIEF published on 06/18/2025 at 07:05, 1 year ago PHAXIAM Therapeutics suspends trading of its shares Euronext Paris Innovative Treatments PHAXIAM Suspension Of Quotation Delisting Securities
PRESS RELEASE published on 06/18/2025 at 07:00, 1 year ago Inside Information / Other news releases PHAXIAM Therapeutics suspends trading shares for delisting on Euronext Paris market. No reimbursement to shareholders. Company focuses on innovative phage-based treatments for resistant bacterial infections Trading Delisting Suspension PHAXIAM Therapeutics Phage-based Treatments
BRIEF published on 06/05/2025 at 07:05, 1 year 1 month ago PHAXIAM Therapeutics Facing Potential Liquidation Amid Court Hearing Postponement Biopharmaceuticals Judicial Liquidation Court Hearing PHAXIAM Therapeutics Euronext Delisting
PRESS RELEASE published on 06/05/2025 at 07:00, 1 year 1 month ago Inside Information / Other news releases PHAXIAM Therapeutics announces new postponement of Offer Review Hearing by Lyon Commercial Court to June 11, 2025. Company to request delisting from Euronext Euronext Delisting Postponement PHAXIAM Therapeutics Lyon Commercial Court
BRIEF published on 03/14/2025 at 17:50, 1 year 3 months ago PHAXIAM Therapeutics seeks buyer in receivership Euronext Paris PHAXIAM Therapeutics Judicial Recovery Looking For A Buyer Extension Of Procedure
PRESS RELEASE published on 03/14/2025 at 17:45, 1 year 3 months ago Inside Information / Other news releases PHAXIAM Therapeutics launches bidding process to find buyers amid receivership, trading of shares to resume on Euronext Paris. Court decides on procedure extension on April 30, 2025 Euronext Paris Receivership PHAXIAM Therapeutics Court Decision Bidding Process
BRIEF published on 03/06/2025 at 18:01, 1 year 3 months ago PHAXIAM Therapeutics Enters Receivership and Delays Financial Results Trading Suspension Financial Results Delay PHAXIAM Receivership Biotech Challenges Court-appointed Administrator
PRESS RELEASE published on 03/06/2025 at 17:56, 1 year 3 months ago Inside Information / Other news releases PHAXIAM Therapeutics announces the opening of a receivership procedure and postponement of its 2024 financial results publication. The company continues operations under observation period Financial Results Biopharmaceutical Company PHAXIAM Therapeutics Receivership Procedure Phage-based Treatments
BRIEF published on 03/06/2025 at 11:45, 1 year 4 months ago Suspension of the Listing of PHAXIAM Therapeutics Euronext Paris Biopharmaceutical PHAXIAM Therapeutics Suspension Of Quotation Resistant Infections
BRIEF published on 12/30/2024 at 17:50, 1 year 6 months ago PHAXIAM Therapeutics: Promising results from the PhagoDAIR pilot study Infection Control PHAXIAM Therapeutics Phase II GLORIA PhagoDAIR Study Anti-S. Aureus Phages
Published on 07/06/2026 at 14:30, 43 minutes ago As the Ebola Epidemic Spreads, NanoViricides Advances Towards a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola in DR Congo
Published on 07/06/2026 at 14:15, 58 minutes ago Gold Terra Announces C$9.7 Million Life Offering, Including Participation From Strategic Shareholder David Harquail
Published on 07/06/2026 at 14:00, 1 hour 13 minutes ago Rio Grande Resources Confirms High-Grade Gold and Silver Including 46.3 g/t Gold and 1,030 g/t Silver in Channel Samples as it Advances Toward Phase 1 Drilling at its Winston Project, New Mexico
Published on 07/06/2026 at 13:15, 1 hour 58 minutes ago 55 North Mining Inc. Announces Name Change to "55 North Gold Inc." and Election of Two New Directors
Published on 07/06/2026 at 15:05, 8 minutes ago OneLayer Recognized in the Gartner® Hype Cycle™ for Private Networks for Industry, 2026
Published on 07/06/2026 at 15:05, 8 minutes ago TMRW Vault® Receives CE Mark Under the European Medical Device Regulation (MDR)
Published on 07/06/2026 at 15:00, 13 minutes ago Hakluyt launches the Hakluyt Essay Prize in collaboration with the Times Literary Supplement
Published on 07/06/2026 at 14:35, 38 minutes ago Bitmine Immersion Technologies (BMNR) Announces ETH Holdings Reach 5.74 Million Tokens, and Total Crypto and Total Cash Holdings of $11.1 Billion
Published on 07/06/2026 at 14:25, 48 minutes ago Circus Appoints Former Aviation and Automotive Executive as New Co-CEO/CFO
Published on 07/06/2026 at 10:59, 4 hours 14 minutes ago Statement of transactions in own shares from June 29, 2026 to July 3, 2026
Published on 07/06/2026 at 08:00, 7 hours 13 minutes ago EURAZEO CLOSES FIFTH-GENERATION SECONDARIES PROGRAMME AT €2.3 BILLION, EXCEEDING TARGET
Published on 07/06/2026 at 07:00, 8 hours 13 minutes ago Thales to acquire the Gorgé family’s stake in Exail with a view to launching a tender for 100% of the company
Published on 07/03/2026 at 21:49, 2 days 17 hours ago Safran announces the end of negotiations regarding the contemplated acquisition of Exail Technologies.
